These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6246753)

  • 1. Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue.
    Reisine TD; Rossor M; Spokes E; Iversen LL; Yamamura HI
    Adv Biochem Psychopharmacol; 1980; 21():443-50. PubMed ID: 6246753
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in brain opiate receptors in Parkinson's disease.
    Reisine TD; Rossor M; Spokes E; Iversen LL; Yamamura HI
    Brain Res; 1979 Sep; 173(2):378-82. PubMed ID: 226215
    [No Abstract]   [Full Text] [Related]  

  • 4. Consequences of perinatal drug administration on brain development: striatal opiate receptors and dopamine.
    Moon SL
    NIDA Res Monogr; 1985; 62():129-45. PubMed ID: 3001526
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder.
    Cross AJ; Crow TJ; Ferrier IN; Johnstone EC; McCreadie RM; Owen F; Owens DG; Poulter M
    J Neural Transm Suppl; 1983; 18():265-72. PubMed ID: 6135745
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
    Seeman P
    Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride.
    Seeman P; Niznik HB; Guan HC
    Arch Gen Psychiatry; 1990 Dec; 47(12):1170-2. PubMed ID: 2244801
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
    Mjörndal T; Winblad B
    Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain enkephalin receptors in Parkinson's disease.
    Rinne UK; Rinne JK; Rinne JO; Laakso K; Tenovuo O; Lönnberg P; Koskinen V
    J Neural Transm Suppl; 1983; 19():163-71. PubMed ID: 6321647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
    Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
    Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased dopamine-receptor sensitivity in schizophrenia.
    Owen F; Cross AJ; Crow TJ; Longden A; Poulter M; Riley GJ
    Lancet; 1978 Jul; 2(8083):223-6. PubMed ID: 79025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report.
    Wong DF; Wagner HN; Pearlson G; Dannals RF; Links JM; Ravert HT; Wilson AA; Suneja S; Bjorvvinssen E; Kuhar MJ
    Psychopharmacol Bull; 1985; 21(3):595-8. PubMed ID: 4034877
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptors in schizophrenia.
    Gjedde A; Reith J; Wong D
    Lancet; 1995 Nov; 346(8985):1302-3. PubMed ID: 7475750
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone.
    Hägglund J; Aquilonius SM; Eckernäs SA; Hartvig P; Lundquist H; Gullberg P; Långström B
    Acta Neurol Scand; 1987 Feb; 75(2):87-94. PubMed ID: 2953165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.
    Arnett CD; Wolf AP; Shiue CY; Fowler JS; MacGregor RR; Christman DR; Smith MR
    J Nucl Med; 1986 Dec; 27(12):1878-82. PubMed ID: 3491193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lithium and sodium ions on opiate- and dopamine-receptor binding.
    Wajda IJ; Banay-Schwartz M; Manigault I; Lajtha A
    Neurochem Res; 1981 Mar; 6(3):321-31. PubMed ID: 6269012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental relationships between opiate receptors and dopamine in the formation of caudate-putamen patches.
    van der Kooy D
    Brain Res; 1984 Jun; 316(2):300-3. PubMed ID: 6087996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.